Objectives Diabetes mellitus (DM) is a long-standing and non-transmissible endocrine
disease that generates significant clinical issues and currently affects approximately 400 …

Lifestyle modifications, metformin, and linagliptin reduce the incidence of type 2 diabetes
(T2D) in people with prediabetes. The gut microbiota (GM) may enhance such interventions' …

Methods This cohort study included patients who were registered as having TB in the
National Tuberculosis Surveillance System. The medical and death records of matched …

Metformin, one of the most frequently used oral glucose-lowering drugs (GLDs), is
associated with the occurrence of gastrointestinal (GI) adverse events in approximately 20 …

Diabetes is a long-term metabolic disorder caused by issues with insulin production or
response in the body. This leads to high levels of glucose in the blood, which can cause …

Diabetes and its associated complications have increasingly become major challenges for
global healthcare. The current therapeutic strategies involve insulin replacement therapy for …

Background For decades, metformin has been the drug of first choice in the management of
type 2 diabetes. However, approximately 2–13% of patients do not tolerate metformin due to …

Insulin resistance (IR), accompanied by an impaired cellular glucose uptake, characterizes
diverse pathologies that include, but are not limited to, metabolic disease, prediabetes and …

A study of the stability of inclusion complexes of chlorpropamide and α, β, γ, and HP-β
cyclodextrin, has been carried out using molecular dynamics simulations. The contribution of …

Multidrug resistance is a serious problem in modern medicine and the reason for the failure
of various therapies. A particularly important problem is the occurrence of multidrug …